Triple

T2138581
Position Surface form Disambiguated ID Type / Status
Subject Lucentis E46708 entity
Predicate isRelatedDrug P24601 FINISHED
Object faricimab
Faricimab is a bispecific monoclonal antibody used to treat neovascular eye diseases such as wet age-related macular degeneration and diabetic macular edema by targeting both VEGF-A and Ang-2 pathways.
 E238184 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: faricimab | Statement: [Lucentis, isRelatedDrug, faricimab]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: faricimab
Context triple: [Lucentis, isRelatedDrug, faricimab]
  • A. Taltz
    Taltz is a prescription biologic medication (ixekizumab) used to treat moderate to severe plaque psoriasis and certain types of arthritis by targeting the inflammatory protein IL-17A.
  • B. Emgality
    Emgality is a prescription monoclonal antibody medication used for the prevention and treatment of migraine and cluster headaches.
  • C. Tecentriq
    Tecentriq is an immunotherapy cancer drug (atezolizumab) that targets the PD-L1 protein to help the immune system attack tumors in various cancers.
  • D. Stelara
    Stelara is a prescription biologic medication (ustekinumab) used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn’s disease by targeting specific immune system pathways.
  • E. Darzalex
    Darzalex is a monoclonal antibody drug (daratumumab) used primarily in the treatment of multiple myeloma.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: faricimab
Triple: [Lucentis, isRelatedDrug, faricimab]
Generated description
Faricimab is a bispecific monoclonal antibody used to treat neovascular eye diseases such as wet age-related macular degeneration and diabetic macular edema by targeting both VEGF-A and Ang-2 pathways.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: faricimab
Target entity description: Faricimab is a bispecific monoclonal antibody used to treat neovascular eye diseases such as wet age-related macular degeneration and diabetic macular edema by targeting both VEGF-A and Ang-2 pathways.
  • A. Taltz
    Taltz is a prescription biologic medication (ixekizumab) used to treat moderate to severe plaque psoriasis and certain types of arthritis by targeting the inflammatory protein IL-17A.
  • B. Emgality
    Emgality is a prescription monoclonal antibody medication used for the prevention and treatment of migraine and cluster headaches.
  • C. Tecentriq
    Tecentriq is an immunotherapy cancer drug (atezolizumab) that targets the PD-L1 protein to help the immune system attack tumors in various cancers.
  • D. Stelara
    Stelara is a prescription biologic medication (ustekinumab) used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn’s disease by targeting specific immune system pathways.
  • E. Darzalex
    Darzalex is a monoclonal antibody drug (daratumumab) used primarily in the treatment of multiple myeloma.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a88a174ab48190a5db20c132e5dccf completed March 4, 2026, 7:37 p.m.
NER Named-entity recognition batch_69abc5af20808190902031d8c0bba376 completed March 7, 2026, 6:29 a.m.
NED1 Entity disambiguation (via context triple) batch_69ae51b1290c8190a08850b428c99a6c completed March 9, 2026, 4:50 a.m.
NEDg Description generation batch_69ae55923b748190bf7a2df3ae94edc8 completed March 9, 2026, 5:07 a.m.
NED2 Entity disambiguation (via description) batch_69ae55fdc32c8190b6ecdc9b23d64cc5 completed March 9, 2026, 5:09 a.m.
Created at: March 4, 2026, 7:44 p.m.